Your browser doesn't support javascript.
loading
Assessment of the prognostic value of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in perihilar cholangiocarcinoma patients following curative resection: A multicenter study of 333 patients.
Ge, Ming-Yang; Liu, Zhi-Peng; Pan, Yu; Wang, Jiao-Yang; Wang, Xiang; Dai, Hai-Su; Gao, Shu-Yang; Zhong, Shi-Yun; Che, Xiao-Yu; Zuo, Jing-Hua; Liu, Yun-Hua; Liu, Xing-Chao; Fan, Hai-Ning; Chen, Wei-Yue; Wang, Zi-Ran; Yin, Xian-Yu; Bai, Jie; Zhang, Yan-Qi; Jiang, Yan; Gong, Yi; Chen, Zhi-Yu.
Affiliation
  • Ge MY; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Liu ZP; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Pan Y; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Wang JY; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Wang X; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Dai HS; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Gao SY; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Zhong SY; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Che XY; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Zuo JH; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Liu YH; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Liu XC; Department of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, Chengdu, China.
  • Fan HN; Department of Hepatobiliary Surgery, Affiliated Hospital of Qinghai University, Xining, China.
  • Chen WY; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Wang ZR; Clinical Research Center of Oncology, Lishui Hospital of Zhejiang University, Lishui, China.
  • Yin XY; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Bai J; Department of General Surgery, 903rd Hospital of People's Liberation Army, Hangzhou, China.
  • Zhang YQ; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Jiang Y; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
  • Gong Y; Department of Health Statistics, College of Military Preventive Medicine, Third Military Medical University (Army Medical University), Chongqing, China.
  • Chen ZY; Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.
Front Oncol ; 12: 1104810, 2022.
Article in En | MEDLINE | ID: mdl-36686802

Full text: 1 Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Type: Article Affiliation country: China

Full text: 1 Database: MEDLINE Type of study: Clinical_trials / Prognostic_studies Language: En Journal: Front Oncol Year: 2022 Type: Article Affiliation country: China